Three of the most widely studied healthy dietary patterns are associated with lower incidence of type 2 diabetes (T2D), regardless of an individual's ethnicity.

Polygenic scores (PGSs) for body mass index (BMI) can improve obesity prediction, according to a study published online.

The FDA has approved a labeling update for Leqvio (inclisiran) allowing for first-line use in the treatment of hypercholesterolemia.

Relatives bereaved by natural death with high and sustained grief symptoms have increased mental health care use and mortality for up to 10 years after the loss.

The FDA has granted clearance for the CardioTag device to assess cardiac function and improve patient outcomes across various healthcare settings.

In patients with diabetic wounds, copper oxide impregnated dressings were noninferior to standard negative pressure wound therapy.

Sarilumab and tocilizumab are equally effective in reducing organ support duration and death in patients who are critically ill with COVID-19.

Researchers have found that use of retinal vascular analysis for prediction of stroke risk is superior to traditional prediction models.

Local anesthetic poisoning reports decreased following publication of advisories in 2010, but reports of lidocaine poisoning and mortality have increased.

Moderate to severe OSA was associated with increased risk for severe and critical COVID-19, particularly in those with severe intermittent hypoxia.

Researchers determined second malignant neoplasms and cardiovascular disease present a persistent and meaningful risk for mortality among survivors of HL.

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.